Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

Local Institution - 0028, New York

Local Institution - 0015, Orbassano

Local Institution - 0020, Berlin

Local Institution - 0019, Rostock

Local Institution - 0010, Madrid

Local Institution - 0008, Málaga

Local Institution - 0014, Oviedo

Local Institution - 0003, Pessac

Local Institution - 0009, Las Palmas de Gran Canaria

Local Institution - 0017, Florence

Local Institution - 0002, Vandœuvre-lès-Nancy

Local Institution - 0013, Chicago

Local Institution - 0021, Mannheim

Local Institution - 0030, Pierre-Bénite

Local Institution - 0011, Dallas

Local Institution - 0012, Paris

Local Institution - 0027, Napoli

Local Institution - 0022, Ulm

Local Institution - 0029, Los Angeles

Local Institution - 0006, Duarte

Local Institution - 0001, San Franisco

Local Institution - 0025, Catania

Local Institution - 0024, Hackensack

Local Institution - 0023, Houston

Local Institution - 0005, Toronto

Local Institution - 0026, Aachen

Local Institution - 0018, Roma

Local Institution - 0016, Rome